[Tasavallan Presidentin virallinen vierailu Saksan Liittotasavaltaan 6.5.-9.5.1979] (tasavallan presidentti Urho Kekkosen vastaus liittokansleri Helmut Schmidtin lounaalla pitämään puheeseen Bonnissa 8.5.1979)

Puhe

The inositol Inpp5k 5-phosphatase affects osmoregulation through the vasopressin-aquaporin 2 pathway in the collecting system.

Inositol Inpp5k (or Pps, SKIP) is a member of the inositol polyphosphate 5-phosphatases family with a poorly characterized function in vivo. In this study, we explored the function of this inositol 5-phosphatase in mice and cells overexpressing the 42-kDa mouse Inpp5k protein. Inpp5k transgenic mice present defects in water metabolism characterized by a reduced plasma osmolality at baseline, a delayed urinary water excretion following a water load, and an increased acute response to vasopressin. These defects are associated with the expression of the Inpp5k transgene in renal collecting ducts and with alterations in the arginine vasopressin/aquaporin-2 signalling pathway in this tubular segment. Analysis in a mouse collecting duct mCCD cell line revealed that Inpp5k overexpression leads to increased expression of the arginine vasopressin receptor type 2 and increased cAMP response to arginine vasopressin, providing a basis for increased aquaporin-2 expression and plasma membrane localization with increased osmotically induced water transport. Altogether, our results indicate that Inpp5k 5-phosphatase is important for the control of the arginine vasopressin/aquaporin-2 signalling pathway and water transport in kidney collecting ducts.

Eversti Aimo Pajunen 10/12 1973

Kirje 10.12.1973

Agronomi Veikko Ihamuotila 3/12 1973

Kirje 3.12.1973

Relatório dos Progressos Realizados para Atingir os ODM

Com o virar do século a Organização das Nações Unidas (ONU) decidiu que era propício e muito simbólico dar um novo impulso à própria Organização e comprometeu-se a combater a pobreza e as doenças que vitimam milhões de crianças em todo o mundo, a maioria das quais com menos de cinco anos, devido a causas totalmente evitáveis como a malária, a diarreia e a pneumonia. Assim, a 8 de Setembro de 2000, 189 Estados membros das ONU adoptaram os “Objectivos de Desenvolvimento do Milénio” (ODM) surgidos da Declaração do Milénio. Foram definidos oito objectivos — cada um deles, um compromisso específico para inverter a propagação da pobreza e das doenças — que são suportados por um Plano de Acção com 18 metas quantificáveis para combater a pobreza, a fome, a doença, o analfabetismo, a discriminação contra a mulher e a degradação ambiental. Muitas das metas dos ODM reflectem um nível de ambição modesto em termos de desenvolvimento humano que os países da ONU se comprometeram a atingir até 2015. Os Objectivos representam igualmente uma parceria entre países desenvolvidos e em desenvolvimento tendo em vista criar um clima a nível nacional e mundial conducente ao desenvolvimento e à eliminação da pobreza. Essa parceria atribui responsabilidades muito claras aos países ricos em termos de prestação de mais ajuda; estabelecimento de regras comerciais mais justas; e alívio significativo da dívida dos países em desenvolvimento. Por seu turno os países em desenvolvimento comprometem-se a vencer o desafio que os ODM colocam. Cabo Verde aceitou o desafio lançado pela ONU para implementar um conjunto de acções estratégicas para que até o ano 2015 um conjunto de objectivos e metas seja realizado. Essa assumpção impõe a integração das metas e indicadores ODM nas políticas públicas nacionais.

Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society

In this study of the efficacy and safety of isradipine as first-line therapy in hypertension, 1,647 patients enrolled; 1,472 completed the 4-week placebo run-in period and began treatment with isradipine at 2.5 mg twice daily for 4 weeks. During placebo, 11% (n = 175) of the 1,647 patients withdrew because of normalization of blood pressure, side effects, noncompliance, violation of the study protocol, side effects from concomitant therapy, or other reasons. During isradipine therapy (n = 1,376), blood pressure decreased from 168 +/- 18/102 +/- 8 mm Hg at the end of the placebo period to 155 +/- 17/94 +/- 9 mm Hg after 2 weeks (p less than 0.001) and 151 +/- 16/92 +/- 9 mm Hg after 4 weeks (p less than 0.001). During active treatment, 6.4% (n = 94) were withdrawn because of flushing, headache, edema, palpitations, gastrointestinal side effects, skin rashes, or other side effects, and two patients because of lack of efficacy. The side effect score in the remaining patients worsened for flushing, remained unchanged for edema, but significantly improved for palpitations, fatigue, dizziness, headache, and nervousness. After 4 weeks, 60% of patients had diastolic blood pressures of less than or equal to 90 mm Hg. Thus, isradipine is effective and safe as first-line therapy in patients with primary hypertension as seen in general practice.

Heidelberg 24/XI -31

Kirje 24.11.1931

Effect of reducing sensory and environmental stimuli during hospitalized premature infant sleep

OBJECTIVETo compare the total sleep time of premature infant in the presence or absence of reducing sensory and environmental stimuli in the neonatal unit.METHODLongitudinal study in a Neonatal Intermediate Care Unit of a public hospital in Sao Paulo. The sample consisted of 13 premature infants. We used polysomnograph and unstructured observation for data collection. We analyzed 240 and 1200 minutes corresponding to the periods of the presence and absence of environmental management, respectively. Data were compared in proportion to the total sleep time in the two moments proposed by the study.RESULTSThe total sleep time in periods without environmental management was on average 696.4 (± 112.1) minutes and with management 168.5 (± 27.9) minutes, proportionally premature infant slept an average of 70.2% during periods with no intervention and 58.0% without management (p=0.002).CONCLUSIONReducing stimulation and handling of premature infant environment periods was effective to provide greater total sleep time.

Lost in translation : euro-compatibility, legal security, and the autonomous implementation of EU law in Switzerland

This article presents the legislative and judicial practice relating to the "autonomous implementation" of EU law in Switzerland. Given that "euro-compatibility" is the central consideration behind this legislative policy, one would expect Swiss authorities to have devised legislative and hermeneutical techniques guaranteeing high fidelity to EU "mother law". That is not the case, however, and as this article shows much is lost in the translation from EU to Swiss Law